Related Experiment Video
Updated: Dec 14, 2025
07:35
Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
Published on: July 8, 2025
813
A taxonomy of seizure dynamotypes
Maria Luisa Saggio1, Dakota Crisp2, Jared M Scott2
1Aix Marseille Univ, Inserm, INS, Institut de Neurosciences des Systèmes, Marseille, France, Marseille, France.
Elife
|July 22, 2020
Summary
Researchers developed a new objective Taxonomy of Seizure Dynamics (TSD) to classify seizures based on their evolving patterns. This framework reveals all 16 predicted seizure dynamotypes in over 2000 focal-onset seizures, offering new patient stratification methods.
Area of Science:
- Neuroscience
- Complex Systems Science
- Computational Biology
Background:
- Seizures represent a widespread disruption of normal brain activity across diverse species and conditions.
- Current clinical classifications for seizures lack objective dynamical criteria.
- Understanding seizure dynamics is crucial for developing targeted therapies and research directions.
Purpose of the Study:
- To introduce an objective, data-driven Taxonomy of Seizure Dynamics (TSD) based on bifurcation theory.
- To define and identify 'dynamotypes' as the fundamental units of seizure dynamics.
- To explore the prevalence and characteristics of these dynamotypes in human focal-onset seizures.
Main Methods:
- Application of bifurcation theory to model seizure dynamics.
- Analysis of over 2000 focal-onset seizures from multiple independent centers.
- Development and validation of the Taxonomy of Seizure Dynamics (TSD) framework.
Main Results:
- Evidence for all 16 predicted dynamotypes within the TSD was found in the analyzed seizure data.
- Patient dynamotypes were observed to evolve over a lifetime.
- Systematic variations in dynamotypes were identified, including hierarchy, non-bijectivity, and pairing preferences.
Conclusions:
- The TSD provides a novel, objective method for classifying seizure dynamics.
- This taxonomy offers a complementary approach to existing clinical seizure classifications.
- The TSD framework facilitates a deeper understanding of seizure evolution and guides future research into dynamical properties.
Related Concept Videos
01:13Seizures: Classification
1.2K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.2K
01:24Epilepsy and Seizures: Overview
1.0K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.0K
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
699
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
699
01:28Classification of Skeletal Muscle Relaxants
2.9K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.9K
01:30Classification of Neurotransmitters
4.7K
Neurotransmitters play a crucial role in the communication between neurons in the autonomic nervous system. Neurons in the autonomic nervous system can be cholinergic or adrenergic depending on the neurotransmitters synthesized. Cholinergic neurons use acetylcholine as their primary neurotransmitter. This includes all the preganglionic fibers of the sympathetic and pre- and postganglionic fibers of the parasympathetic nervous systems. In addition, neurons of the somatic nervous system also use...
4.7K